Vascular Solutions Inc. (VASC) Reaches New 52-Week High at $49.77
Vascular Solutions Inc. (NASDAQ:VASC)’s share price hit a new 52-week high on Friday . The company traded as high as $49.77 and last traded at $48.61, with a volume of 24,374 shares. The stock had previously closed at $48.46.
A number of brokerages recently weighed in on VASC. Sidoti cut Vascular Solutions from a “buy” rating to a “neutral” rating and set a $47.00 price target on the stock. in a research note on Tuesday, July 12th. Piper Jaffray Cos. lifted their price target on Vascular Solutions from $45.00 to $49.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 26th. TheStreet raised Vascular Solutions from a “hold” rating to a “buy” rating in a research note on Monday, July 25th. Canaccord Genuity reissued a “buy” rating on shares of Vascular Solutions in a research note on Wednesday, August 10th. Finally, Zacks Investment Research raised Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a research note on Thursday, July 28th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Vascular Solutions presently has a consensus rating of “Buy” and a consensus target price of $47.38.
The company has a market cap of $856.88 million and a PE ratio of 90.72. The firm has a 50-day moving average price of $46.13 and a 200 day moving average price of $38.07.
Vascular Solutions (NASDAQ:VASC) last announced its quarterly earnings results on Monday, July 25th. The medical device company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.03. During the same quarter last year, the company earned $0.29 earnings per share. The company earned $41.20 million during the quarter, compared to the consensus estimate of $41.40 million. The business’s revenue was up 9.7% on a year-over-year basis. Equities analysts expect that Vascular Solutions Inc. will post $1.24 earnings per share for the current fiscal year.
In other Vascular Solutions news, VP William Rutstein sold 10,011 shares of the business’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $46.26, for a total value of $463,108.86. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Howard Root sold 40,000 shares of the business’s stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $45.11, for a total value of $1,804,400.00. Following the completion of the transaction, the chief executive officer now directly owns 347,840 shares in the company, valued at approximately $15,691,062.40. The disclosure for this sale can be found here.
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.